Benufutamab Antibody
Benufutamab (GEN1029) is a DR5-targeting agonistic antibody developed for oncology research. It induces apoptosis in tumor cells and has demonstrated anti-tumor activity in preclinical studies of solid tumors, supporting its investigation in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
Hx-DR5-01, Hx-DR5-05, GEN1029, GEN 1029
Target
Apoptosis, TNF
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
6.2 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
145.1 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![FITC Anti-Human CD274/PD-L1 Antibody[29E.2A3]](https://cdn.genprice.uk/products/763/68dd14af061270361e7d37e1/imageurl/e-ab-f1133c.webp)
E-AB-F1133C-01 20 Tests
FITC Anti-Human CD274/PD-L1 Antibody[29E.2A3]
Sign In for Pricing
View Details E-AB-F1133C-02 100 Tests
FITC Anti-Human CD274/PD-L1 Antibody[29E.2A3]
Sign In for Pricing
View Details E-AB-F1133C-03 2x 100 Tests
FITC Anti-Human CD274/PD-L1 Antibody[29E.2A3]
Sign In for Pricing
View Details 
TP320730L 1 mg
POLR2J2 (POLR2J3) (NM_001097615) Human Recombinant Protein
Sign In for Pricing
View Details 